Botanical species · safety record

Krameria lappacea

The EFSA Compendium of Botanicals holds 8 constituent measurements for Krameria lappacea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Krameria lappacea (Dombey) Burdet & B.B.Simpson

8Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Krameria triandra Ruiz & Pav.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Lignans	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Proanthocyanidins (condensed tannins)	Roots and other underground parts	Solvent extraction	≤ 1.89 Per mille	HPLC-FD	Resolve DOI
Proanthocyanidins (condensed tannins)	Roots and other underground parts	Solvent extraction	≥ 1.35 Per mille	HPLC-FD	Resolve DOI
Tannins	Roots and other underground parts	Solvent extraction	≤ 7 Percent	Unspecified	Resolve DOI
Tannins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Tannins	Roots and other underground parts	Solvent extraction	≥ 6.1 Percent	Unspecified	Resolve DOI
Lignans	Roots and other underground parts	Solvent extraction	—	LC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

M�ller, C., Hansen, S.H., Cornett, C. Characterisation of tannin-containing herbal drugs by HPLC. Phytochemical analysis, 2009, vol. 20, no. 3, p. 231-239. DOI
Pascual, ME., Carretero, ME., Slowing, KV., Villar, A. Simplified screening by TLC of plant drugs. Pharmaceutical biology, 2002, vol. 40, no. 2, p. 139-143. DOI
Baumgartner, Lisa., Sosa, Silvio., Atanasov, Atanas G., Bodensieck, Antje., Fakhrudin, Nanang., Bauer, Julia., Del Favero, Giorgia., Ponti, Cristina., Heiss, Elke H., Schwaiger, Stefan., Ladurner, Angela., Widowitz, Ute., Della Loggia, Roberto., Rollinger, Judith M., Werz, Oliver., Bauer, Rudolf., Dirsch, Verena M., Tubaro, Aurelia., Stuppner, Hermann. Lignan Derivatives from Krameria lappacea Roots Inhibit Acute Inflammation in Vivo and Pro-inflammatory Mediators in Vitro . Journal of natural products, 2011, vol. 74, no. 8, p. 1779-1786. DOI
Maffei Facino, R., Carini, M., Aldini, G., De Angelis, L. A rapid screening by liquid chromatography/mass spectrometry and fast-atom bombardment tandem mass spectrometry of phenolic constituents with radical scavenging activity, from Krameria triandra roots . Rapid communications in mass spectrometry, 1997, vol. 11, no. 12, p. 1303-1308.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature